Coalition for Epidemic Preparedness Innovations & Richard Hatchett

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) is a key funder, committing approximately $60 million to accelerate the development of Ebola Bundibugyo vaccines, and is crucial in coordinating the global response.

Richard Hatchett: Dr. Richard Hatchett>>>, CEO of Coalition for Epidemic Preparedness Innovations>>>, emphasized the urgency of funding to advance safe and effective vaccines against the Bundibugyo virus.

Coalition for Epidemic Preparedness Innovations: Global partnership funding vaccine development; new CEO appointment ensures continuity and strategic implementation of its 2027-2031 plan.

Richard Hatchett: Outgoing CEO, praised for leadership since 2017; transition to Abubakar is managed smoothly.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) is funding three groups, including Moderna and the University of Oxford, to accelerate the development of vaccines against the Bundibugyo strain of Ebola.

Richard Hatchett: Dr. Richard Hatchett, CEO of CEPI, emphasizes the urgency of developing licensed vaccines for the rapidly spreading Bundibugyo virus, stating that 'every day counts'.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) funds vaccine development and is assessing potential Ebola vaccine candidates, aiming for a rapid response.

Richard Hatchett: Richard Hatchett>>>, head of the Coalition for Epidemic Preparedness Innovations>>>, expressed high concern about the outbreak's control challenges.